Predictors of Plasmodium falciparum Infection in the First Trimester Among Nulliparous Women From Kenya, Zambia, and the Democratic Republic of the Congo.
early pregnancy
factors
first-trimester
malaria
predictors
pregnancy
prevalence
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
received:
30
04
2021
accepted:
07
12
2021
pubmed:
11
12
2021
medline:
7
6
2022
entrez:
10
12
2021
Statut:
ppublish
Résumé
Malaria can have deleterious effects early in pregnancy, during placentation. However, malaria testing and treatment are rarely initiated until the second trimester, leaving pregnancies unprotected in the first trimester. To inform potential early intervention approaches, we sought to identify clinical and demographic predictors of first-trimester malaria. We prospectively recruited women from sites in the Democratic Republic of the Congo (DRC), Kenya, and Zambia who participated in the ASPIRIN (Aspirin Supplementation for Pregnancy Indicated risk Reduction In Nulliparas) trial. Nulliparous women were tested for first-trimester Plasmodium falciparum infection by quantitative polymerase chain reaction. We evaluated predictors using descriptive statistics. First-trimester malaria prevalence among 1513 nulliparous pregnant women was 6.3% (95% confidence interval [CI], 3.7%-8.8%] in the Zambian site, 37.8% (95% CI, 34.2%-41.5%) in the Kenyan site, and 62.9% (95% CI, 58.6%-67.2%) in the DRC site. First-trimester malaria was associated with shorter height and younger age in Kenyan women in site-stratified analyses, and with lower educational attainment in analyses combining all 3 sites. No other predictors were identified. First-trimester malaria prevalence varied by study site in sub-Saharan Africa. The absence of consistent predictors suggests that routine parasite screening in early pregnancy may be needed to mitigate first-trimester malaria in high-prevalence settings.
Sections du résumé
BACKGROUND
Malaria can have deleterious effects early in pregnancy, during placentation. However, malaria testing and treatment are rarely initiated until the second trimester, leaving pregnancies unprotected in the first trimester. To inform potential early intervention approaches, we sought to identify clinical and demographic predictors of first-trimester malaria.
METHODS
We prospectively recruited women from sites in the Democratic Republic of the Congo (DRC), Kenya, and Zambia who participated in the ASPIRIN (Aspirin Supplementation for Pregnancy Indicated risk Reduction In Nulliparas) trial. Nulliparous women were tested for first-trimester Plasmodium falciparum infection by quantitative polymerase chain reaction. We evaluated predictors using descriptive statistics.
RESULTS
First-trimester malaria prevalence among 1513 nulliparous pregnant women was 6.3% (95% confidence interval [CI], 3.7%-8.8%] in the Zambian site, 37.8% (95% CI, 34.2%-41.5%) in the Kenyan site, and 62.9% (95% CI, 58.6%-67.2%) in the DRC site. First-trimester malaria was associated with shorter height and younger age in Kenyan women in site-stratified analyses, and with lower educational attainment in analyses combining all 3 sites. No other predictors were identified.
CONCLUSIONS
First-trimester malaria prevalence varied by study site in sub-Saharan Africa. The absence of consistent predictors suggests that routine parasite screening in early pregnancy may be needed to mitigate first-trimester malaria in high-prevalence settings.
Identifiants
pubmed: 34888658
pii: 6458120
doi: 10.1093/infdis/jiab588
pmc: PMC9159331
doi:
Substances chimiques
Aspirin
R16CO5Y76E
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
2002-2010Subventions
Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Malar J. 2014 Jul 15;13:274
pubmed: 25023697
Lancet Infect Dis. 2007 Feb;7(2):105-17
pubmed: 17251081
Lancet Infect Dis. 2007 Feb;7(2):93-104
pubmed: 17251080
Clin Infect Dis. 2015 Feb 15;60(4):598-604
pubmed: 25362205
BMC Med. 2017 Jun 21;15(1):117
pubmed: 28633672
Reprod Health. 2020 Dec 17;17(Suppl 3):193
pubmed: 33334359
Am J Trop Med Hyg. 2011 Aug;85(2):214-20
pubmed: 21813837
Diagn Microbiol Infect Dis. 2016 May;85(1):16-8
pubmed: 26915637
Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):
pubmed: 28213434
Hum Pathol. 2000 Jan;31(1):85-93
pubmed: 10665918
J Infect Dis. 2017 Dec 19;216(12):1601-1610
pubmed: 29029247
Malar J. 2018 Oct 5;17(1):352
pubmed: 30290815
Lancet. 2020 Jan 25;395(10220):285-293
pubmed: 31982074
Malar J. 2013 Apr 24;12:139
pubmed: 23617626
PLoS One. 2013;8(1):e53794
pubmed: 23326508
J Infect Dis. 2018 Mar 28;217(8):1309-1317
pubmed: 29325055
Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):586-92
pubmed: 12625128
PLoS Med. 2017 Feb 28;14(2):e1002243
pubmed: 28245259
Am J Trop Med Hyg. 1996;55(1 Suppl):17-23
pubmed: 8702032
J Infect Dis. 2019 Sep 26;220(9):1396-1398
pubmed: 30590709
Trop Med Int Health. 2001 Oct;6(10):770-8
pubmed: 11679125
Clin Infect Dis. 2015 May 15;60(10):1481-8
pubmed: 25694651
BMC Pregnancy Childbirth. 2017 May 3;17(1):135
pubmed: 28468653
Lancet. 2014 May 17;383(9930):1739-47
pubmed: 24559537
Am J Surg Pathol. 1998 Aug;22(8):1006-11
pubmed: 9706981
PLoS Med. 2019 Oct 1;16(10):e1002914
pubmed: 31574087
Malar J. 2017 Oct 24;16(1):427
pubmed: 29065884
Parasit Vectors. 2011 Jun 18;4:113
pubmed: 21682919
J Reprod Immunol. 2005 Feb;65(1):1-15
pubmed: 15694963
Lancet Infect Dis. 2018 Apr;18(4):e119-e132
pubmed: 29395997
J Infect Dis. 2019 Sep 26;220(9):1425-1434
pubmed: 30590576